CTLA4 and neoplasm: Furthermore, immune checkpoint inhibitors (ICIs) like anti-CTLA-4 antibody or anti-TIGIT antibody combined with the blockade of CD25 potently resulted in the depletion of Tregs and enhanced anti-tumor responses in a mouse model (Arce Vargas et al., 2017).